Loading the player…
⌘K
Forward · Real Salt Lake · Compare
at PHISat, Oct 10, 7:30 PM ETMatch page →William Agada (Forward, Real Salt Lake) has 2 goals and 2 assists in 28 MLS appearances in 2025.
Last match
A yes-only price keeps the books' margin, so there is no fair chance to compare his rate with.
William Agada's full breakdown holds the game-by-game chart, hit-rate splits and filters, the what-if line and market curve, every book and the line history, closing lines, the projected range, teammates and matchup tools. Checking your player views…
Checking your player views…2024 and 2025
| Date | Opp | Result | Min | G | A | Shots | SOT | Fouls | YC |
|---|---|---|---|---|---|---|---|---|---|
| Oct 22 · P | at POR | L 1–3 | 25* | 0 | 0 | 2 | 0 | 0 | 0 |
| Oct 18 | at STL | D 2–2 | 7* | 0 | 0 | 0 | 0 | 0 | 0 |
| Oct 11 | at SEA | L 0–1 | 45* | 0 | 0 | 1 | 0 | 1 | 0 |
| Oct 4 | vs COL | W 1–0 | 20* | 0 | 0 | 0 | 0 | 1 | 0 |
| Sep 21 | at LAFC | L 1–4 | 31* | 0 | 0 | 3 | 0 | 0 | 0 |
| Sep 17 | vs LAFC | L 1–4 | 7* | 0 | 0 | 0 | 0 | 1 | 0 |
| Sep 13 | vs SKC | W 2–1 | 18* | 0 | 0 | 1 | 0 | 3 | 0 |
| Aug 16 | at CLT | L 0–1 | 28* | 0 | 0 | 4 | 2 | 2 | 1 |
| Aug 10 | at RBNY | L 1–2 | 64 | 0 | 1 | 1 | 0 | 0 | 0 |
| Jul 26 | vs SJ | W 2–1 | 79 | 0 | 0 | 0 | 0 | 1 | 0 |
Showing 10 of 68 games. The full game log is part of the player's full breakdown (a free account opens 5 players a day; Pro has no limit).
2025
100 = the most per 90 among forwards; a tie counts half. Rates are goals, assists, shots and shots on target per 90 minutes in league matches. Key passes are not tracked.
40 shots charted in 28 matches · 7 on target · 2 goals
Tap or hover a shot for details.
From box scores (minutes are worked out from the substitutions; * = came off the bench). Prop prices from BetMGM, FanDuel, theScore Bet, DraftKings and Caesars when posted; a yes-only price keeps the books' margin. Hit rates are past matches, not a forecast or a pick. For information only, not betting advice. 21+ only. Gambling problem? Call or text 1-800-GAMBLER.